Search results for "Anticoagulation"


 
Results 11 - 20 of about 232 for "Anticoagulation".
Sort by: Relevance | Newest | Oldest

Amiodarone increases bleeding compared with flecainide or sotalol in patients on anticoagulant therapy

A retrospective analysis of Medicare patients who started an anticoagulant and then amiodarone found that they had a 44% increased risk for bleeding-related hospitalization compared to those on other antiarrhythmics and that this risk was higher with rivaroxaban than apixaban.
https://immattersacp.org/weekly/archives/2023/05/23/1.htm
23 May 2023

Updated Beers criteria highlight medications that are risky in older patients

The American Geriatrics Society has added warfarin as a medication to avoid and urged caution with sodium-glucose cotransporter-2 inhibitors in the latest update of its guidance on prescribing for U.S. adults ages 65 years and older.
https://immattersacp.org/weekly/archives/2023/05/16/1.htm
16 May 2023

Cognitive impairment common after stroke

A scientific statement from the American Heart Association/American Stroke Association called for collaboration among primary care physicians, subspecialist doctors, and other health professionals to identify and manage cognitive problems after stroke.
https://immattersacp.org/weekly/archives/2023/05/09/4.htm
9 May 2023

Take TIAs as seriously as a stroke

Internal medicine physicians play a critical role in educating patients about the seriousness of transient ischemic attacks and preventing their recurrence.
https://immattersacp.org/archives/2023/05/take-tias-as-seriously-as-a-stroke.htm
1 May 2023

MKSAP Quiz: Evaluation for easy bruising

A 48-year-old woman is evaluated for easy bruising. She has no history of gingival bleeding, menorrhagia, or bleeding following procedures. Following a physical exam and lab studies, what is the most appropriate diagnostic test?
https://immattersacp.org/weekly/archives/2023/03/28/3.htm
28 Mar 2023

Use of warfarin down, DOACs up in commercially insured patients with cirrhosis, nonvalvular afib

While more than half of eligible patients with cirrhosis and concurrent nonvalvular atrial fibrillation did not receive anticoagulation between 2012 and 2019, use of direct oral anticoagulants (DOACs) increased substantially during that time, a recent study found.
https://immattersacp.org/weekly/archives/2023/01/17/4.htm
17 Jan 2023

DOACs more effective, cost-effective than LMWH for cancer-associated thrombosis

A meta-analysis compared three direct oral anticoagulants (DOACs) (apixaban, edoxaban, and rivaroxaban) to low-molecular-weight heparin (LMWH) and found that apixaban was usually the most cost-effective option, but that finding hinged on the specific drug price.
https://immattersacp.org/weekly/archives/2023/01/03/5.htm
3 Jan 2023

IM physicians join health inspections at the border

Two ACP members toured Customs and Border Protection (CBP) facilities near the Texas/Mexico border to evaluate the processes and environmental conditions affecting human health at the facilities.
https://immattersacp.org/archives/2023/01/im-physicians-join-health-inspections-at-the-border.htm
1 Jan 2023

AHA statement reviews efficacy, safety of CAM therapies in patients with heart failure

Potentially beneficial complementary and alternative medicine (CAM) therapies included omega-3 polyunsaturated fatty acids, coenzyme Q10, D-ribose, and L-carnitine, the American Heart Association (AHA) said.
https://immattersacp.org/weekly/archives/2022/12/13/1.htm
13 Dec 2022

Patients with provoked VTE often on anticoagulation longer than recommended

Three variables were associated with receiving anticoagulation for longer than three months after a provoked venous thromboembolism (VTE): direct oral anticoagulant use, history of VTE, and history of myocardial infarction.
https://immattersacp.org/weekly/archives/2022/11/01/4.htm
1 Nov 2022

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next